Timothy J. Hagen joined the NIU faculty as an assistant professor of organic chemistry in August 2010. He received his bachelor's degree from Illinois State University and his Ph.D. degree from the University of Wisconsin—Milwaukee. He did postdoctoral research for Searle.
Prior to NIU, Professor Hagen worked in the pharmaceutical industry as a synthetic organic and medicinal chemist for more than 20 years. He worked for Searle, Pharmacia/Pfizer (same company which underwent multiple mergers) and deCODE. He is an author on 41 journal articles, an inventor on 42 patents and patent applications and a contributing author to three books. One of the compounds he worked on at Pfizer, SD‐6010, is currently in Phase II clinical trials for the treatment of osteoarthritis.
Hagen's research will focus on organic synthesis and medicinal chemistry. The focus is on synthesis of small molecules that can modulate essential pathways of infectious disease organisms. The disease targets include parasitic diseases and bacterial infections. The Hagen lab utilizes protein fragment‐based screening, de novo drug design and natural product chemistry to explore enzyme inhibition and selectivity. Read more >